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Srijan Jindal1,2,3, Lei Yang4, Philip J. Day2,3 and Douglas B. Kell1,2,4,5*Abstract
Background: It is widely believed that most xenobiotics cross biomembranes by diffusing through the
phospholipid bilayer, and that the use of protein transporters is an occasional adjunct. According to an alternative
view, phospholipid bilayer transport is negligible, and several different transporters may be involved in the uptake
of an individual molecular type. We recognise here that the availability of gene knockout collections allows one to
assess the contributions of all potential transporters, and flow cytometry based on fluorescence provides a
convenient high-throughput assay for xenobiotic uptake in individual cells.
Results: We used high-throughput flow cytometry to assess the ability of individual gene knockout strains of E coli
to take up two membrane-permeable, cationic fluorescent dyes, namely the carbocyanine diS-C3(5) and the DNA
dye SYBR Green. Individual strains showed a large range of distributions of uptake. The range of modal steady-state
uptakes for the carbocyanine between the different strains was 36-fold. Knockouts of the ATP synthase α- and β-
subunits greatly inhibited uptake, implying that most uptake was ATP-driven rather than being driven by a
membrane potential. Dozens of transporters changed the steady-state uptake of the dye by more than 50% with
respect to that of the wild type, in either direction (increased or decreased); knockouts of known influx and efflux
transporters behaved as expected, giving credence to the general strategy. Many of the knockouts with the most
reduced uptake were transporter genes of unknown function (‘y-genes’). Similarly, several overexpression variants in
the ‘ASKA’ collection had the anticipated, opposite effects. Similar results were obtained with SYBR Green (the range
being approximately 69-fold). Although it too contains a benzothiazole motif there was negligible correlation
between its uptake and that of the carbocyanine when compared across the various strains (although the
membrane potential is presumably the same in each case).
Conclusions: Overall, we conclude that the uptake of these dyes may be catalysed by a great many transporters of
putatively broad and presently unknown specificity, and that the very large range between the ‘lowest’ and the
‘highest’ levels of uptake, even in knockouts of just single genes, implies strongly that phospholipid bilayer
transport is indeed negligible. This work also casts serious doubt upon the use of such dyes as quantitative stains
for representing either bioenergetic parameters or the amount of cellular DNA in unfixed cells (in vivo). By contrast,
it opens up their potential use as transporter assay substrates in high-throughput screening.
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The presence, number, nature, and physiological status of
bacteria is widely assessed using fluorescent dyes [1–9].
Some of these stain particular molecules or macromole-
cules such as DNA [10], protein [11] or lipid [12], while
others reflect physiological variables such as pH, the
concentrations of other ions and small molecules, or the
extent of membrane energisation [13]. In some cases (e.g.
[6, 8]), cells are permeabilised before staining, such that
the natural ability of stains to reach their intracellular tar-
gets is not an issue. However, studies of in vivo physiology
[9, 14–16] necessarily require that native, intact cells are
used. In Gram-negative cells, entry to the periplasm is me-
diated via porins [17], which can affect the ability of stains
such as rhodamine 123 and other cations to be accumu-
lated [18–20], while intracellular concentrations of stain
may also be modified by the activities of influx and efflux
transporters.
Although it is often assumed and stated that intact cells
take up xenobiotics mainly according to their hydrophobi-
city (lipophilicity) [21–23], and generally by ‘passive diffu-
sion’ through the limited phospholipid bilayer areas that
exist, an abundance of evidence indicates that this is not
in fact the case [24–26] and that ‘phospholipid bilayer
transport is negligible’ [27]. Those xenobiotics that pass
through the membrane, which necessarily include xeno-
biotic fluorescent probes, must thus be taken up by
protein-based transporters, and the question arises as to
which ones [28, 29]. In mammalian cells, for instance,
fluorescein can be transported by an active monocarboxyl-
ate transporter [30].
Since the amount of fluorescence is often used as a
quantitative indicator of the amount of the relevant
determinand, it is obvious that the involvement of such
transporters might significantly obscure the true values
that would result if transporter-mediated membrane
permeability or translocation was not occurring or was
kinetically irrelevant. An early indication of this was the
recognition that the apparent failure of ethidium brom-
ide to stain intracellular DNA inside intact (live) E. coli
cells was almost entirely due to the overwhelming activ-
ity of an efflux pump whose activity was much reduced
at 0 °C [31]. The relevant efflux pumps were not then
identified, but it is now well established that ethidium
bromide is a very good substrate for ‘efflux’ transporters
such as the multisubunit acrAB-tolC complex [32] and
the small molecule resistance (SMR) protein emrE [33].
Concentrative transporters (whether influx or efflux)
need additional sources of free energy. In E. coli these are
typically the energised membrane (often seen as a mem-
brane potential or a protonmotive force [34]) generated
via electron transport (that can also be used to synthesise
ATP), or ATP itself acting directly. The latter is signifi-
cantly more common in prokaryotes [35]. However, it isoften considered that the uptake of more or less lipophilic
cations into bacteria or mitochondria is driven by a
negative-inside membrane potential, whose concentration
ratio reflects it according to the Nernst equation and
thereby allows one to infer it (see Discussion).
Many non-fluorescent drugs, including anti-infectives,
can simply be seen as xenobiotics, and systematic studies
have been performed to see the extent to which the loss of
effluxers (and occasionally of influxers) modulates their
toxicity [36, 37]. In particular, the AcrAB-TolC complex
spans inner and outer membranes, is constitutively
expressed, and is considered to play a major role in multi-
drug resistance [38–42]. Consequently, the activities of ef-
flux transporters are widely recognised both as major
mediators of microbial resistance to antibiotics and as tar-
gets for ameliorating it [43–69]. However, such activities
cannot yet be predicted reliably (e.g. [70–72]). Efflux
transporters are also important in pharmacokinetics, not
least by effecting the export of anticancer drugs in mam-
malian systems (e.g. [53, 73–76]). They can also play im-
portant roles in the biotechnological production of small
molecules and/or their biotransformations [77, 78].
Since efflux transporters are required to remove such
intracellular molecules that have been taken up by cells,
it is reasonable that influx transporters were exploited to
get them there in the first place [24–27]. However, in
the case of bacteria, knowledge of the specific influx and
efflux transporters for individual xenobiotics is surpris-
ingly limited, albeit many efflux transporters can be
quite promiscuous [79–81].
Although they can be interfered with by coloured
compounds [82], an understanding of the transporters
used in the uptake and efflux of fluorescent probes in in-
tact microbial cells is of interest for a number of reasons:
(i) as with mammalian cells [83–86], they can provide
substrates for competitive or trans-stimulation-type
uptake assays, (ii) they provide examples of substrates
that can be used in the development of quantitative
structure-activity relationships (QSARs) for the effluxers
themselves, and (iii) they allow us to assess the limita-
tions of any individual fluorescent probe assay where the
expression levels of relevant transporters is not known
or controlled [87]. It is already known that even lipid
stains such as Nile Red [88–91] and membrane energisa-
tion stains such as bis-(1,3-dibutylbarbituric acid tri-
methine oxonol) (commonly known as DiBAC4(3)) are
in fact efflux substrates of acrAB-tolC [92], while other
widely used stains that are effluxed via acrAB-tolC in-
clude the Hoechst dye H33342 [93], berberine [94], resa-
zurin [95], and rhodamine 6G [96]. What is much less
well known is which if any other efflux transporters are
involved, and which influx transporters may have been
responsible for the uptake of such commonly used
fluorophores in the first place.
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K12 strain MG1655 [97], and an equivalent programme in
baker’s yeast [98, 99], it was soon recognised that much sci-
entific value would accrue to the possession of a collection
of single-gene knockouts (of ‘non-essential’ genes), and this
was produced as the ‘Keio collection’ [100–102] http://
ecoli.iab.keio.ac.jp/. Flow cytometry provides a convenient
means of estimating the steady-state uptake of fluorescent
probes in bacteria [9], and while efflux pumps have been
analysed elegantly in this way [44] the combination of flow
cytometry and the Keio collection seemed to provide an
ideal opportunity to assess the contribution of individual
transporter genes (i.e. their products) to the uptake
and efflux of widely used fluorescent probes. We used
TransportdB http://www.membranetransport.org/trans-
porter2.php?oOID=ecol1 [103] to pick out the most
pertinent subset of transporters, to which we added a
few more strains whose knockouts were involved in
ATP synthesis, and report the findings herein. It is
concluded that every probe used can exploit a wide
variety of transporters for both influx and efflux, add-
itional to reporting on their nominal determinand of
interest. This is consistent with the view [27, 29, 104]
that most xenobiotics that enter cells can be taken up
and/or effluxed by multiple transporters of varying
specificities. A preprint has been lodged at bioRxiv
(https://www.biorxiv.org/content/10.1101/603688v1).
Results
Variation of the uptake of a lipophilic carbocyanine cation
3,3′-Dipropylthiadicarbocyanine iodide (IUPAC name(3-
Propyl-2-{(1E,3E,5E)-5-(3-propyl-1,3-benzothiazol-2(3H)-
ylidene)-1,3-pentadien-1-yl}-1,3-benzothiazol-3-ium iod-
ide, Fig. 1), commonly known as diS-C3(5) [105, 106], is a
cationic carbocyanine dye that is accumulated by bacteriaFig. 1 Chemical structures of some molecules described in this article(both Gram-positive and Gram-negative) with energised
membranes. Although culturability is the conventional
metric for bacterial ‘viability’ [107, 108], diS-C3(5) has
been exploited widely in microbiology to detect nominally
‘viable’ bacteria (at least those with intact membranes) in
clinical, laboratory and environmental samples, especially
using flow cytometry (e.g. [109–113]). Metabolising
yeast cells can also accumulate it [114–118]. We note
that the extent of fluorescence is not necessarily fully
linear with concentration because of dye stacking
[105, 106, 119] (and see [120]) but is at least assumed
to be more or less monotonic.
The strategy used to assess diS-C3(5) uptake, gating
on light scattering in ‘forward’ and ‘side’ directions by
the bacteria and assessing uptake via red fluorescence
(which is not interfered with by any autofluores-
cence), is precisely as was described previously [121].
It is obvious (Fig. 2) that even in the wild-type strain
there is considerable heterogeneity in the distribution
of uptake between individual cells; this becomes even
greater for the cells (ΔatpB) lacking the β subunit of
the membrane ATP synthase. Figure 3 shows the
mode fluorescence for the wild type strain and for
knockouts of known transporter and certain other
genes; the wild type and some of these are labelled in
Fig. 3. The dataset (and all the other KOs described
herein) is given in full as an Excel sheet in Additional
file 1: Table S1. (Note that we have strong suspicions
that the supposed tolC knockout was not in fact a
knockout of tolC.) The very great breadth and com-
plex shapes of the distributions is considered to be
underpinned by the significant number of transporters
involved, especially those driven by ATP, and their
heterogeneous expression level distributions between
individual cells [107].
Fig. 2 Typical cytograms of the wild-type strain (WT) stained (save for
the no-dye control) with diS-C3(5) as described in Methods, along with
other knockout strains. Those deleted in atpB or acrA are labelled with
the relevant colours. Experiments were performed as described in the
Materials and Methods section
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major break points, one after the lowest 75 and one before
the highest 15 in terms of their effects on the steady-state
uptake of DiS-C3(5). Several other important features
emerge from this plot (Fig. 3). (i) the range of steady-state
uptake over the family of single-gene knockouts is very
substantial, i.e. some 36-fold between the lowest and high-
est mode uptake, (ii) this range is somewhat asymmetric,
in that the highest values are just two-fold greater than is
that of the wild type (although we cannot exclude trunca-
tion due to fluorescence quenching [105]), while the lowest
value is ~ 18 times lower; (iii) the number of (y-)genes ofFig. 3 Variation in the mode uptake of diS-C3(5) into different knockout str
were performed as described in the legend to Fig. 3. Experiments were peunknown function that are uptake transporters (or whose
removal most decreases the uptake of diS-C3(5)), encoded
in red, is far greater than is the number of unknown efflux-
ers (or those whose removal most increases its uptake; the
three highest such y-genes are ygfQ, ydcS and ybbW,
Table 1), (iv) the five highest values include four known
drug effluxers (mdtJ, acrA, mdtI, mdtA), giving confidence
in the strategy; (v) 297 knockouts are higher and 244 lower.
If a cutoff of 50% above or below the WT is taken (fluores-
cence levels < 128,000 or > 384,000), we still have 115
knockouts below and 33 knockouts above these thresholds.
While we do not know which ones are operating under
each condition, this does imply the potential contribution
of a very considerable number of transporters to the
steady-state uptake of the dye, which is, of course, consist-
ent with the very broad range of uptakes of an individual
dye in a given cytogram (Fig. 2); (vi) even if all of the up-
take in the most ‘potent’ knockout was through the
phospholipid bilayer, and none through ion-coupled trans-
porters, for instance, this uptake (one thirty-sixth of that of
the highest strain) would be less than 3% of it, which we
regard as negligible. We note that ybbW has been anno-
tated as a putative uptake transporter for allantoin [136]
(http://www.tcdb.org), but in this case it must at least be
an antiporter, since its knockout causes a large increase in
dye uptake. Such findings also illustrate that there remain
many mis-annotations or incomplete annotations of the E.
coli transporterome.
A referee has helpfully pointed out that some of the y-
genes (as designated in the Keio collection terminology
we have used (and retain) throughout), now have more
secure functions, and these alternative non-y-gene desig-
nations appear in Table 1 and Additional file 1. Otherains of the Keio collection as judged by flow cytometry. Experiments
rformed as described in the Materials and Methods section
Table 1 A selected subset of the most effective knockouts in terms of their ability to affect the uptake of diS-C3(5)
Gene Comments Uniprot ID Representative reference(s)
atpB F1-ATPase subunit P0ABB0 [122]
atpA F1-ATPase subunit P0AB98 [122]
ycdG (rutG) Broad-specificity pyrimidine permease P75892 [123–125]
rbsB Ribose ABC transporter periplasmic binding protein P02925 [126]
ybiO mechanosensitive ion channel P75783 [127]
yifK probable transport protein (possibly amino acid) P27837 [128]
yliA/gsiA ATP-driven Glutathione importer P75796 [129]
ybiR Inner membrane protein P75788 (none)
yccS Inner membrane protein P75870 (none)
phoR Phosphate sensor regulon P08400 [130]
yejA Putative oligopeptide ABC transporter periplasmic binding protein P33913 [131]
mdtI Spermidine export protein P69210 [132, 133]
mdtJ Spermidine export protein P69212 [133]
mdtL Multidrug resistance protein (e.g. vs chloramphenicol) P31462 [133]
mdtA Multidrug resistance protein (e.g. vs novobiocin) P76397 [134]
acrA Multidrug efflux pump subunit P0AE06 [135]
ybbW Putative allantoin permease P75712 [136]
ydcS Part of ABC transporter complex, possibly involved in
poly-β-hydroxybutyrate synthesis/ polyamine efflux
P76108 [137]
ygfQ (ghxQ) Hypoxanthine-guanine permease Q46817 [138]
Those whose knockout increased uptake are given in bold face
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found in Ecocyc.
Although it was not financially reasonable to determine
any compensating or pleiotropic changes [139] at the level
of the genome-wide transcriptome for these many hun-
dreds of experiments, the simplest explanation for such
data is that an increase in uptake following a knockout
denotes the removal of an efflux transporter, while a de-
crease denotes that an influx transporter (or its source of
free energy) has been knocked out. Either there are a
massive number of pleiotropic effects on a smaller num-
ber of transporters or there are least 115 influx and 34
efflux transporters for diS-C3(5) (or both). Similarly, this
vast (36-fold) range of uptake levels is not obviously con-
sistent with the fact that uptake might reflect a membrane
potential, although the activity of at least acrAB/tolC is in
fact considered to be enhanced by an energised mem-
brane. Indeed, the lowering of uptake in the ΔatpA/B
knockouts, that would be expected to have a higher mem-
brane potential [140], makes it absolutely clear that the
uptake cannot mainly be driven by such a potential, but
instead by ATP directly (generated by substrate-level
phosphorylation). We note that a tolC knockout did not
result in major changes in uptake (although it might be
expected to inhibit many RND-type efflux pump activ-
ities), but it seems that this strain may have had a muta-
tion elsewhere as tolC was still present as judged bycolony PCR and our own attempts to remove it were un-
successful. Similar suspicion applies to acrB (Fig. 3, which
would be anticipated to lie near acrA). But the general
principle remains clear: individual gene knockouts lead to
a huge range in the steady-state uptake of the dye that
cannot be ascribed to changes in a membrane potential
with which its distribution might equilibrate.
To confirm these general findings, we took a few of the
gene designations whose removal in the Keio collection led
to the greatest or lowest uptake, and assessed their behav-
iours in the corresponding strains in the ASKA collection
of overexpressed genes. As anticipated, overexpression of
these effluxers lowered the uptake levels to less than that of
the wildtype, while overexpression of putative uptake trans-
porters raised the steady-state level of their uptake consid-
erably (Fig. 4), albeit not to the levels of the highest effluxer
KOs, implying some spare kinetic capacity in the latter.
To analyse more closely the main conclusion of this sec-
tion – that the steady-state uptake level of the diS-C3(5)
molecule is determined significantly by multiple proteins in-
cluding transporters – we highlight some of the most signifi-
cant knockouts in Table 1. A number are unsurprising,
which gives confidence in the idea that our basic method is
sound. Among the most potent of the non-transporters at
inhibiting uptake were knockouts of the genes encoding the
two main (α and β) subunits of the membrane ATP syn-
thase, implying strongly that the uptake transporters were
Fig. 4 Effect of overexpression and knockout of a series of genes whose knockout causes major changes (both up and down) in the modal
uptake of diSC3(5) relative to that of the wild type. Experiments were performed as described in the Materials and Methods section
Fig. 5 Typical cytograms of the uptake of SYBR Green in the wild-
type strain (WT) and some other, knockout strains stained with SYBR
Green as described in Methods (save for the no-dye control), along
with other knockout strains
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transport-derived energised membrane (often referred to as
a protonmotive force). This is consistent with the relative
prevalence of ATP-driven transporters in prokaryotes [35].
The complement of y-genes of unknown or poorly
annotated function stands at around 35% of the total,
with transporters being over-represented among them
[141]. It is of particular interest that so many y-genes
are represented among the KOs showing the biggest
effects; clearly we have much to learn, as with mammalian
cell transporters of pharmaceutical drugs [142, 143], about
their ‘natural’ substrates.
It is of course entirely arbitrary to pick the top few only
(all are given in the Additional file 1), and we would add
that one set of interest is represented by potC and potE (as
well as other products of pot genes) that are components of
a (cationic) sperm(id) ine import/efflux system [144–147].
Obviously it is entirely reasonable that this might serve,
when active, to remove a cation such as diS-C3(5), and the
fact that the potent effluxers mdtI and mdtJ are also
spermi(di)ne effluxers (Table 1) lends weight to this view.
In a similar vein, the KOs of mdtH and mdtK [132] have a
significantly reduced uptake; although they were originally
tagged as effluxers (in the sense of multidrug transporters),
it seems more likely that they are in fact antiporters, nor-
mally contributing to the uptake (here) of the cyanine dye.
SYBR Green
SYBR Green is another cationic dye, and increases its
fluorescence massively on binding to (especially) double-
stranded DNA [10, 148]. It is considered to be ‘mem-
brane-permeable’ (by whatever means) and it is widely
used both in environmental and general microbiology(e.g. [10, 148–152]) and in mammalian cell biology (e.g.
[153]). SYBR Green also contains a benzothiazole motif
(Fig. 1), and using our standard methods of cheminfor-
matics [143, 154, 155], we noted that SYBR Green and
DiS-C3(5) have a Tanimoto similarity to each other of
0.731 when encoded using the RDKit (www.rdkit.org)
“patterned” fingerprint.
A similar experiment to that performed with diS-C3(5)
was performed with SYBR Green. Typical cytograms of
SYBR Green uptake are shown in Fig. 5, and the full set of
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Fig. 6. Again there is a huge range of uptakes (69-fold),
the lowest being ~five-fold lower and the largest approxi-
mately thirteen-fold greater than that of the wild type. Be-
cause of the greater range, and the occasionally bimodal
peaks such as that for ΔatpG in Fig. 5, the median fluores-
cence values are given on a logarithmic scale. All data are
again given in Additional file 1: Table S1. Some of this
variation can of course reflect differences in the DNA con-
tent of the cells, since this is a function of the earlier
growth rate [156, 157], though this typically does not ex-
ceed about 8 chromosome contents even at the fastest
growth rates [121, 158], so variations in DNA content
alone could not conceivably explain this range. We there-
fore also performed growth rate experiments for almost
all the strains tested; there was no correlation between the
uptake of SYBR green and either the growth rate (Fig. 7,
r2 ~ 0.02) or the stationary phase OD (Fig. 8, r2 ~ 0.015),
indicating clearly that variations in DNA content were not
a significant contributor to these findings in intact cells.
By contrast with the diS-C3(5) data (Fig. 3), there are
considerable differences (Fig. 9), in that the phoR knockout
now shows the second greatest uptake (rather than the
eighth lowest). Again there is a considerable preponderance
of y-genes in the part of the figure where their removal
lowers uptake relative to the wild type. A subset of genes
with the ‘highest’ and ‘lowest’ effects is given in Table 2.
Despite the fact that both dyes contain a benzothiazole
motif, there is absolutely no correlation (r2 ~ 0.002) be-
tween the uptake of the two dyes in individual knockouts
(Fig. 6). Thus, mdtL and nagE are among the highest for
diS-C3(5) but among the lowest for SYBR Green, while
the converse is true for phoR, zntA (zinc/lead-transportngFig. 6 Median uptake in ranked order of SYBR Green uptake into E. coli sin
Y-genes are encoded in red. Experiments were performed as described inATPase) and yifK (‘probable amino acid transporter pro-
tein’). This is despite the presumption that the putative
membrane potential with which their uptake might equili-
brate is the same in the same strains. Such findings imply
that some transporters have a fairly unusual specificity,
even if they are labelled (as is mdtL) as multidrug resist-
ance proteins. In the case of SYBR Green, the heterogen-
eity in uptake can clearly contribute to the heterogeneity
in staining observed [10] when cells are not permeabilised.
It was also of interest to assess the effect of chemical
inhibitors on the ability of transporter knockouts to take
up SYBR Green. In contrast to earlier work [170] where
we studied effects on gene transcription, the interest here
was in direct, acute effects. Table 3 shows the effects of a
few such molecules, that of chlorpromazine, a known in-
hibitor of acrAB activity [171–173], and clozapine (a
second-generation anti-psychotic) [174] being particularly
striking. Note (see Methods) that different conditions
were used from those of Figs. 2, 3, 4, 5 and 6. The very
large increase upon chlorpromazine addition (more than
25-fold) might be taken to imply that it can inhibit mul-
tiple effluxers, and suggests that it might be a useful
adjunct therapy in cases of antimicrobial resistance.
Discussion
There is present lively debate as to whether a majority of
xenobiotic uptake through cellular membranes occurs
via whatever phospholipid bilayer may be present, or
whether Phospholipid Bilayer diffusion Is Negligible (a
view referred to as “PBIN”; [27, 175]). In this latter view,
it is recognised that potentially a great many transporters
can and do interact with a given molecule [27, 175] (see
also [29]). This would be unsurprising given that thegle-gne knockout strains, with a small subset of gene names marked.
the Materials and Methods section
Fig. 7 Lack of relationship between the median extent of uptake of SYBR Green and growth rate. Y-genes are encoded in red. Experiments were
performed as described in the Materials and Methods section
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ceutical drugs is ~six [26, 176]. The present data are
entirely consistent with (indeed lend strong support to)
this view.
If a closed biological cell or organelle maintains a
transmembrane electrical potential difference Δψ relative
to that of its adjacent, external phase, it is in principle
possible to estimate that potential by allowing a freely
membrane-permeable (usually lipophilic) ion to come
into a Nernstian equilibrium with it (e.g. [177–186]). For
a negative-inside potential, and concentrative uptake by
a lipophilic cation such as methyltriphenylphosphoniumFig. 8 Lack of relationship between the median extent of uptake of SYBR G
Experiments were performed as described in the Materials and Methods se(TPMP+), Δψ may be related to the ratio of internal ain
and external aout activities of the ions by:
ΔΨ ¼ −2:3 RT=zFð Þ log ain=aoutð Þ ð1Þ
where T is the absolute temperature, R the universal gas
constant, F Faraday’s constant, and z the charge on the lipo-
philic cation. RT/F is about 60mV at room temperature,
such that a Δψ of 60mV equates to a concentration ratio
for a monovalent cation of 10:1, a Δψ of 120mV a concen-
tration ratio of 100, and so on. It is often assumed that the
uptake of such lipophilic cationic dyes by bacteria reflectsreen and stationary phase OD. As before, y-genes are encoded in red.
ction
Fig. 9 Relationship between the uptake of SYBR Green (ordinate) and of diS-C3(5) (abscissa). The line is a line of best fit (r2~0.002). Also shown
are some of the knockout labels as discussed in the text. Symbols for y-genes are in red, others in blue. Experiments were performed as
described in the Materials and Methods section
Jindal et al. BMC Microbiology          (2019) 19:195 Page 9 of 16the existence and magnitude of such a transmembrane po-
tential. However, import and export transporters invalidate
such estimations of Δψ, their activities respectively causing
an over- and under-estimate, and this has been shown
clearly to occur for the uptake of dibenzyldimethylammo-
nium in baker’s yeast [70] and of Tl+ in bacteria [187–189].Table 2 A selected subset of the most effective knockouts in terms
Gene Comments
yiaM 2,3-diketo-L-gulonate transporter
setC Putative sugar efflux system
tsgA Uncharacterised transporter
yhjV Uncharacterised transporter
yggT Unknown transporter involved in osmotolerance
actP Cation/acetate symporter
yrbG Possible inorganic cation transporter
yidK Uncharacterised symporter
aaeB p-hydroxybenzoate efflux pump
atpG ATP synthase gamma chain
phoR Phosphate sensor regulon
cysU (cysT) Sulphate transport permease
mdtD Putative multidrug resistance transporter
dctA Dicarboxylate transport protein
yehW Non-osmoprotecting glycine betaine uptake system (pre
Those whose knockout increased uptake are given in bold faceConfidence in any such estimations of Δψ is bolstered if the
equilibrium uptake ratio is independent not only of the con-
centration but the nature of the lipophilic cations employed,
and also of any anions that may be present. In practice, and
although such difficulties are commonly ignored, these re-
quirements are rarely if ever met [177, 179, 190, 191].of their ability to affect the uptake of Sybr Green
Uniprot ID Representative reference(s)
P37674 (none)
B7L779 [159]
P60778 (none)
P37660 [160]
P64564 [161]
P32705 [162]
P45394 [163, 164]
P31448 (none)
P46481 [165–167]
P0ABA6 (none)
P08400 [130]
P16701 (none)
P36554 [159]
P0A830 [168]
sumably antiporter) P33359 [169]
Table 3 Effects of various modifiers on steady-state uptake of
diSC3(5) and SYBR Green by wild-type E. coli. Experiments were
performed as described in Materials and Methods
WT means no inhibitors added. Red and green highlight the most significant
decreases or increases, respectively
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clearly that a variety of cations enter cells via a large
number of transporters, especially those driven by
ATP directly, so whatever their uptake is reflecting it
cannot simply be a bulk transmembrane potential. In-
deed, the loss of ATP synthesis by electron transport-
linked phosphorylation in the ΔatpA and ΔatpB
strains might be expected to increase the level of any
such membrane potential [140] but instead the extent
of uptake is substantially reduced. This is very strong
evidence against any such equilibration of uptake with
a membrane potential. Similarly, the almost complete
lack of correlation between the two cations studies
make it inconceivable that the steady-state uptake re-
flects the value of any membrane potential as it is
presumably the same for each strain when the two
dyes are compared. In the case of SYBR Green, the
data also call into question the use of that dye for es-
timating quantitatively the amount of DNA in live,
non-permeabilised cells, and indeed (using growth
rate as a surrogate [156, 192] for DNA content) no
such relationship was found.
By contrast, a possible benefit of our findings, for
those interested in estimating transporter activities, is
that if overexpression of a particular transporter causes
most of the uptake (or efflux) flux to occur via it (as in
Fig. 4), competition or trans-stimulation assays with a
fluorophore provide a powerful and potentially high-
throughput [44, 193] method for measuring Quantita-
tive structure-activity relationshipss. The fact that the
substrate specificities of individual transporters are typ-
ically rather different from each other (Fig. 6) implies
that there could indeed be much value in pursuing this
more widely.Conclusions
Despite a widespread assumption that xenobiotics, (in-
cluding pharmaceutical drugs such as antibiotics) cross
biomembranes by diffusion through whatever phospho-
lipid bilayer exists, there does not seem to have been a sys-
tematic attempt to assess the contribution of such a flux
to cellular uptake. The availability of systematic gene
knockout collections such as the Keio collection allows an
assessment of every candidate transporter (and other
genes) to the uptake of a substance of interest, and fluor-
escence flow cytometry provides a convenient means of
assessing the extent of that uptake in individual cells. We
have done this for what seems to be the first time. The
very large number of gene knockouts with an extent of
uptake of one or more dyes that is reduced substantially
(i.e. less than half) relative to that of the wild type, as well
as the large ranges between ‘lowest’ and ‘highest’ uptake,
even in only single-gene knockouts, really does attest to
the fact that phospholipid bilayer transport is indeed
negligible. It also casts considerable doubt on the util-
ity of these dyes in vivo in assessing quantitatively
any membrane potential that might exist, or the DNA
content of the cells.
Materials and methods
Bacterial strains
E. coli (K-12, MG1655) was taken from the laboratory
collection of Prof R. Goodacre [194, 195]). The Keio col-
lection of E. coli (K-12, MG1655) was obtained from the
SYNBIOChem group (University of Manchester, UK)
from which a collection of 530 knockouts (188 y-genes)
was selected for the study, mainly those with a trans-
porter protein gene knocked out. The full list is given in
Additional file 1. We recognise that one or two transport
proteins may have been missed (e.g. nupC, as pointed
out by a referee), but the conclusions drawn are not
affected by this. A few strains were selected from the
ASKA collection of E. coli (BW38029) also taken from
SYNBIOChem group. No permissions were required to
use these strains.
Culture
E. coli strains were grown from single colonies on agar
plates in conical flasks using Lysogeny broth (LB) to an
optical density (600 nm) of 1.5–2.0, representing station-
ary phase in this medium. They were held in stationary
phase for 2–4 h before being inoculated at a concentra-
tion of 105 cells.mL− 1 into LB.
Keio collection sample preparation
Singer ROTOR HDA (Singer Instruments, UK), a high
throughput robotic replicator and colony picker, was
used to pick single strains from stock 96-well plates
stored at -80 °C and stamped on nutrient agar plates in
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and strains were then transferred in a 96-well plate with
200μL of LB in each well. The resulting set of six 96-
well plates was incubated overnight at 37 °C and 200
rpm shaking and used later for analysis.
DiSC3(5) and Sybr Green I uptake measurement
Singer RePads 96 long (Singer Instruments, UK), 96-pin
plastic replica-plating pads were used to replicate and
culture the new subset of the Keio collection grown
overnight. 150μL of LB was added in each well with
3 μM (final concentration) of DiSC3(5) This was chosen
because it was an amount that gave a signal roughly an
order of magnitude greater than the undyed control in
the wild type. (Thermo Fisher Scientific, UK) in six U-
bottom 96-well plates. The Singer RePads were used to
transfer individual strains from overnight cultured plates
to the new plates. The plates were sealed with Breath-
able Film (Starlab UK, Ltd.) and incubated at 37 °C for 2
min in the dark. The plates were vortexed at 200 rpm
for 2 min and screened on a Sartorius Intellicyt iQue
Screener Plus™ flow cytometer.
Our variant of this flow cytometer has three fixed exci-
tation lasers (405, 488, 640 nm), forward and side scatter
(from the 488 nm excitation) and 13 fluorescence chan-
nels based on filters. The channels we report here are
mainly BL1 (Ex 488, Em 530 ± 15 nm) and RL1 (Ex 640
nm, Em 675 ± 15 nm). To detect bacteria we gated via
forward scatter and side scatter. This instrument does
not have user-adjustable photomultiplier tubes so the
numbers simply reflect the extent of fluorescence it reg-
isters. The following settings [121] were used for the
flow cytometry: automatic prime – 60 s (in Qsol buffer);
pre-plate shake − 15 s and 900 r.p.m.; sip time − 2 s (ac-
tual sample uptake); additional sip time − 0.5 s (the gap
between sips); pump speed − 29 r.p.m. (1.5 μl.s− 1 sample
uptake); plate model – U- bottom well plate (for 96-well
plates); mid-plate clean-up – after every well (4 washes;
0.5 s each in Qsol buffer); inter-well shake − 900 rpm;
after 11 wells, 4 s in Qsol buffer; flush and clean – 30 s
with Decon and Clean buffers followed by 60 s with de-
ionized water. Fluorescence intensity was measured with
RL1 channel and the Forecyt™ software supplied with
the instrument was used to perform the analysis.
For Sybr Green I (Thermo Fisher Scientific, UK) uptake
measurements, the samples were prepared similarly to
those for DiSC3(5) except that Sybr Green I was added at
10,000x diluted concentration from the original stock as
provided by the supplier (catalogue number S7585). The
sample plates were incubated for 15min and fluorescence
was measured using the BL1 channel.
The fluorescence kinetics experiment was performed
on a Sony SH800 FACS machine. An overnight-grown
culture of E. coli was diluted in LB to a concentration of105 CFU.mL− 1. diSC3(5) dye was added to 10mL of the
bacterial solution at a final concentration of 3 μM in a
50mL amber falcon tube (to prevent photobleaching)
and incubated in the dark at 37 °C for 2 min. Post-
vortexing, the falcon tube was placed in the flow cyt-
ometer and the fluorescence intensity of the sample was
measured for 1 h continuously. Same was repeated with
SYBR Green I.SYBR Green I uptake measurement on fixed Keio strains
A further subset of 20 strains from the previously
analysed Keio collection subset was taken and fixed
by injection in 70% ice-cold ethanol. The cells were
washed twice by centrifugation in 0.1 M-Tris/HCl buf-
fer, pH 7.4, before being resuspended in PBS at the
concentration of 106 CFU.mL− 1. Sybr Green I was
added to the sample at 10,000x diluted concentration
from the stock and the samples were kept at 37 °C in
the dark for 15 min. Samples were added in a U-
bottom 96-well plate and fluorescence intensity was
measured using the BL1 channel.Effect of inhibitors on the fluorescence of dye uptake in
E. coli
A few efflux inhibitors were tested for their effects on
the fluorescence intensity of the bacterial cells. The
stock solutions of the inhibitors were made at 1 mM in
DMSO and 5uL was added in two 96-well plates in trip-
licates. A vacuum centrifuge was used to evaporate all
the DMSO in the plates. 200μL of overnight-cultured E.
coli was added in each well of the plates at 105
CFU.mL− 1 final concentrations. The plates were sealed
and kept at 30 °C and 900 rpm shaking for 30 min. 3uM
of DiSC3(5) and 10,000x diluted Sybr Green I was then
added to the different plates. The plate with DiSC3(5)
was incubated for 2 min while one with Sybr Green I
was incubated for 15 min at 37 °C before being analysed
using the flow cytometer.Screening ASKA collection strains for dye uptake
Selected strains from the ASKA collection were taken
from -80 °C stock and resuscitated in LB with 34 μg.mL− 1
Chloramphenicol. The strains were cultured overnight in
M9 media (M9 Minimal Media: 1x M9 Salts, 2 mM
MgSO4, 0.1 mM CaCl2, 0.2% glucose, 10 μg.mL
− 1
Thiamine HCl and 0.2% Casamino Acids) and 0.5 mM
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added
in the morning and grown for another hour. The strains
were diluted and their fluorescence upon uptake of
DiSC3(5) was measured using the same steps as per-
formed above with the Keio strains.
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measurement
The Growth Profiler 960 (Enzyscreen, NL) is a commercial
instrument (http://www.enzyscreen.com/growth_profiler.
htm) that estimates growth rates using camera-based mea-
surements in up to 10 96-well plates. E. coli was taken from
an overnight culture and diluted to a concentration of 106
CFU.mL− 1. The Keio collection strains were sub-cultured
and samples were prepared using stamping method as de-
scribed above. The strains were stamped in CR1496c Poly-
styrene transparent square 96-half-deepwell microtiter
plates used with CR1396b Sandwich covers in the Growth
Profiler. The samples were prepared in 10 96-well plates
and incubated in the instrument at 37 °C with 225 rpm
shaking (recommended settings). The pictures of the plates
were recorded at 15-min interval. The G values obtained
from these pictures were converted to their respective
OD600 values using the manufacturer’s software, Eq. 1,
and pre-calculated values of the constants (a = 0.0234,
b = 1, c = 1.09E-6, d = 3.41, e = 1.56E-13 and f = 6.58).
Calculated OD600 ¼ a Gvalue GvalueMediumð Þbþ
c Gvalue GvalueMediumð Þdþ
e Gvalue GvalueMediumð Þ f
ð2Þ
In some cases the estimates were clearly far too
high due to outliers; growth rates were truncated at 3
doubling times.h− 1.
Additional file
Additional file 1: Modal and mean uptake data for diS-C3(5) and Sybr
green as described in the body of the paper. (XLSX 55 kb)
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